Current Report Filing (8-k)
November 18 2021 - 4:07PM
Edgar (US Regulatory)
0001831270
false
0001831270
2021-11-18
2021-11-18
0001831270
BITE:UnitsEachConsistingOfOneShareOfCommonStockParValueDollar0.0001PerShareandOneHalfOfOneWarrantMember
2021-11-18
2021-11-18
0001831270
us-gaap:CommonStockMember
2021-11-18
2021-11-18
0001831270
us-gaap:WarrantMember
2021-11-18
2021-11-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of
report (Date of earliest event reported): November 18, 2021
Bite Acquisition
Corp.
(Exact name of registrant as specified in its charter)
Delaware
|
001-40055
|
85-3307316
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
30 West Street, No. 28F
New York, New York
(Address of principal executive offices)
|
10004
(Zip Code)
|
|
(212) 608-2923
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
|
|
Check the appropriate box
below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Units, each consisting of one share of common stock, par value $0.0001 per share and one-half of one warrant
|
|
BITE.U
|
|
The New York Stock Exchange
|
|
|
|
|
|
Common stock, par value $0.0001 per share
|
|
BITE
|
|
The New York Stock Exchange
|
|
|
|
|
|
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
|
|
BITE WS
|
|
The New York Stock Exchange
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 4.02.
|
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report
or Completed Interim Review.
|
In light of recent comments
issued by the U.S. Securities and Exchange Commission (the “SEC”), the management of Bite Acquisition Corp (the “Company”)
has re-evaluated the Company’s application of ASC 480-10-S99-3A to its accounting classification of its redeemable shares of common
stock, par value $0.0001 per share (the “Public Shares”), issued as part of the units sold in the Company’s initial
public offering (the “IPO”) in February 2021. Historically, a portion of the Public Shares was classified as permanent equity
to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial business combination
only if the Company has net tangible assets of at least $5,000,001. Pursuant to such re-evaluation, the Company’s management has
determined that the Public Shares include certain provisions that require classification of the Public Shares as temporary equity regardless
of the minimum net tangible assets required to complete the Company’s initial business combination.
As a result of the foregoing,
on November 18, 2021, the audit committee of the Company’s board of directors concluded, after discussion with the Company’s
management, that the Company’s previously issued (i) audited balance sheet as of February 17, 2021, included in the Company’s
Current Report on Form 8-K filed with the SEC on February 23, 2021, (ii) unaudited interim financial statements included in the Company’s
Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on June 9, 2021, and (iii) unaudited interim
financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed
with the SEC on August 24, 2021 (collectively, the “Affected Periods”), should be restated to report all Public Shares as
temporary equity and should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Periods
and intends to include a footnote in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the “Q3 Form 10-Q”),
reflecting the restatement for the Affected Periods.
The Company does not expect any of the
above changes will have any impact on the amounts previously reported for its cash and cash equivalents or total assets.
The Company’s
Chief Executive Officer and Chief Financial Officer conducted an evaluation of the effectiveness of the design and operation of the Company’s
disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021. Based on this evaluation, the Company’s
Chief Executive Officer and Chief Financial Officer have concluded that as of September 30, 2021, solely due to the events that led to
the Company’s restatement of its financial statements to reclassify all redeemable equity instruments to temporary equity from permanent
equity, a material weakness existed and the Company’s disclosure controls and procedures were not effective. The Company’s
remediation plan with respect to such material weakness will be described in more detail in the Q3 Form 10-Q.
The Company has discussed the matters disclosed
in this Current Report on Form 8-K with its independent registered public accounting firm, Marcum LLP.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
BITE ACQUISITION CORP.
|
|
|
|
|
By:
|
/s/ Axel Molet Warschawski
|
|
|
Name: Axel Molet Warschawski
|
|
|
Title: Chief Financial Officer
|
Date: November 18, 2021
Bite Acquisition (NYSE:BITE)
Historical Stock Chart
From Jan 2025 to Feb 2025
Bite Acquisition (NYSE:BITE)
Historical Stock Chart
From Feb 2024 to Feb 2025